Researchers conducted trials in a variety of cell lines, including breast, cervical, prostate and glioblastoma cancers. The results showed that the new compound was particularly effective against breast cancer cells, being 10 times more active than the standard chemotherapy drug doxorubicin.
The problem of drug resistance of tumor cells remains one of the main problems of modern oncology. Many cells that survive chemotherapy become resistant to a wide variety of drugs.
The resulting compound is patented and can be considered a promising basis for the creation of new pharmaceutical drugs. The study confirmed its ability to inhibit the growth of seven different tumor cell lines.
Scientists continue to investigate the properties of the new substance and its potential use in medicine.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
